EMA makes rec­om­men­da­tions to man­u­fac­tur­ers as it aims to stem drug short­ages

Eu­ro­pean reg­u­la­tors are call­ing on man­u­fac­tur­ers and oth­er play­ers in the sup­ply chain to be more open about drug short­ages at a time when there are short­ages for med­ica­tions rang­ing from amox­i­cillin to Ozem­pic.

The guid­ance pub­lished Wednes­day comes from a task force from the EMA and the Heads of Med­i­cines Agen­cies set up in 2016 to ad­dress short­ages, out­lines meth­ods to bet­ter pre­vent and man­age sup­ply is­sues.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.